This inventor holds 1 USPTO granted patent. Top assignee: Haemonetics Corporation. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Innovations of Stephen Bernt in Apheresis Technology
Introduction
Stephen Bernt is an accomplished inventor based in Dover, MA (US). He has made significant contributions to the field of medical technology, particularly in the area of apheresis. His innovative approach has led to the development of a unique apparatus that enhances the efficiency and effectiveness of blood component collection.
Latest Patents
Stephen Bernt holds a patent for an Adaptive Apheresis Apparatus. This automated system is designed to avoid unnecessary collection and return of blood components. The operator can dial in a desired amount of one or more blood components, and the invention calculates the necessary cycles to achieve the target. It implements an appropriate apheresis procedure, varying the volume of the separation chamber as needed. The invention also includes a return procedure that allows for a portion of the contents to be returned to the donor before the final collection cycle. This ensures that the collection target is met efficiently. Additionally, the apparatus monitors the amount of desired product collected in real-time, calculating the number of cycles required to reach the target level. It continuously compares overall blood collection volumes with the actual volume obtained, thereby computing the machine's collection efficiency for each type of blood product.
Career Highlights
Stephen Bernt is currently associated with Haemonetics Corporation, a company known for its focus on blood management solutions. His work at Haemonetics has been pivotal in advancing apheresis technology, contributing to improved patient outcomes and operational efficiencies in blood collection.
Collaborations
Stephen has collaborated with notable colleagues, including Etienne Pages and Stephen Viviano. Their combined expertise has fostered innovation and development in the medical technology sector.
Conclusion
Stephen Bernt's contributions to apheresis technology exemplify the impact of innovative thinking in the medical field. His patented Adaptive Apheresis Apparatus represents a significant advancement in blood component collection, showcasing his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile